Publication | Open Access

Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study

ThrombosisWorldwide StudyCardiovascular DiseasePharmacologyCardiologyPharmacotherapyPreventive CardiologyThromboembolic PreventionCoagulopathyPlatelet AntagonistMedicineAnticoagulantAtherosclerosisCongenital Heart Disease